The role of gut microbiome in immune modulation in metastatic renal cell carcinoma

Treatment of metastatic renal cell carcinomas (mRCC) has drastically improved since the advent of immunotherapy with immune checkpoint inhibitors (ICIs), with a significant proportion of patients achieving durable responses. While this has revolutionized treatment and improved outcomes for mRCC pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Deluce, Jasna, Maleki Vareki, Saman, Fernandes, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465582/
https://www.ncbi.nlm.nih.gov/pubmed/36105887
http://dx.doi.org/10.1177/17588359221122714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465582/
https://www.ncbi.nlm.nih.gov/pubmed/36105887
http://dx.doi.org/10.1177/17588359221122714

Ejemplares similares